BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Teva Presents New Reslizumab Data At European Respiratory Society (ERS) International Congress 2015

  September 28, 2015

   · 

  8 min read
• Drug Development

  Boehringer Ingelheim Release: ECC 2015: GIOTRIF (Afatinib) Demonstrates Superior Survival Compared To Tarceva (Erlotinib) For Patients With Previously Treated Advanced Squamous Cell Carcinoma Of The Lung, Independent Of EGFR Mutation Status

  September 28, 2015

   · 

  5 min read
• Drug Development

  Boehringer Ingelheim Release: VARGATEF Plus Docetaxel Significantly Reduced Tumour Burden In Lung Cancer Patients With Advanced Adenocarcinoma Compared To Docetaxel Alone

  September 28, 2015

   · 

  5 min read
• Drug Development

  Two Positive Studies Of Genentech’s Investigational Cancer Immunotherapy Atezolizumab In Specific Type Of Lung Cancer Presented At 2015 European Cancer Congress

  September 28, 2015

   · 

  1 min read
• Drug Development

  Puma Biotech Announces Presentation Of Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (Extenet Trial) In Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients

  September 28, 2015

   · 

  6 min read
• Policy

  pSivida Announces NDA For Medidur Now Planned Using Six-Month Efficacy Data From Both Phase III Trials; FDA Concurs

  September 28, 2015

   · 

  6 min read
• Business

  Nonin Medical, Inc.'s Christopher Holland Promoted to Chief Commercial Officer

  September 28, 2015

   · 

  1 min read
• Drug Development

  Kolltan Pharmaceuticals Inc. Announces Presentation Of KTN0158 Preclinical Data At The ESMO Cancer Conference 2015

  September 28, 2015

   · 

  7 min read
• Drug Development

  Palatin Tech Release: Preclinical Data On PL-3994 For Heart Failure And Resistant Hypertension Presented At 2015 Heart Failure Society Of America Annual Meeting

  September 28, 2015

   · 

  4 min read
• Alimera Sciences Announces Availability Of Review Paper On Real World Experience With ILUVIEN

  September 28, 2015

   · 

  6 min read